References
- Cattaruzza MS, Maisonneuve P, Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 1996; 32: 293–305
- Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005; 41: 683–93
- Ronchetti D, Neglia CB, Cesana BM, Carboni N, Neri A, Pruneri G, et al. Association between p53 gene mutations and tobacco and alcohol exposure in laryngeal squamous cell carcinoma. Arch Otol Head Neck Surg 2004; 130: 303–6
- Smith B, Haffty BG, Sasaki CT. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann Otol Rhinol Laryngol 2001; 110: 221–8
- Sarkar FH, Sakr WA, Li YW, Jacobs J, Crissman JD. Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx. Diagn Mol Pathol 1996; 5: 201–5
- Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and non-smoking women. Cancer Epidemiol Biomarkers Prev 1999; 8: 297–302
- Cruz I, Snijders PJF, Van Houten V, Vosjan M, Van der Waal I, Meijer CJLM. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas. J Clin Pathol 2002; 55: 834–40
- Bernardini S, Adessi GL, Chezy E, Billerey C, Carbillet JP, Bittard H. Influence of cigarette smoking on p53 gene mutations in bladder carcinomas. Anticancer Res 2001; 21: 3001–4
- Huang CC, Cheng YW, Chen MC, Lin YS, Chou MC, Lee H. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers. Environ Mol Mutagen 2006; 47: 527–32
- Liloglou T, Scholes AG, Spandidos DA, Vaughan ED, Jones AS, Field JK. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res 1997; 57: 4070–4